D’Souza, A., Brazauskas, R., Stadtmauer, E., Pasquini, M., Hari, P., Bashey, A., … Flynn, K. (2021). Trajectories of symptom and quality-of-life (QOL) recovery after autologous stem cell transplantation (ASCT) in multiple myeloma (MM): secondary analysis of BMT CTN 0702 trial. In QUALITY OF LIFE RESEARCH (Vol. 30, pp. S32–S33).

D’Souza, Anita, Ruta Brazauskas, Edward Stadtmauer, Marcelo Pasquini, Parameswaran Hari, Asad Bashey, Steven Devine, et al. “Trajectories of symptom and quality-of-life (QOL) recovery after autologous stem cell transplantation (ASCT) in multiple myeloma (MM): secondary analysis of BMT CTN 0702 trial.” In QUALITY OF LIFE RESEARCH, 30:S32–33, 2021.

D’Souza A, Brazauskas R, Stadtmauer E, Pasquini M, Hari P, Bashey A, et al. Trajectories of symptom and quality-of-life (QOL) recovery after autologous stem cell transplantation (ASCT) in multiple myeloma (MM): secondary analysis of BMT CTN 0702 trial. In: QUALITY OF LIFE RESEARCH. 2021. p. S32–3.

D’Souza, Anita, et al. “Trajectories of symptom and quality-of-life (QOL) recovery after autologous stem cell transplantation (ASCT) in multiple myeloma (MM): secondary analysis of BMT CTN 0702 trial.” QUALITY OF LIFE RESEARCH, vol. 30, no. SUPPL 1, 2021, pp. S32–33.

D’Souza A, Brazauskas R, Stadtmauer E, Pasquini M, Hari P, Bashey A, Devine S, Efeberra Y, Ganguly S, Gasparetto C, Geller N, Horowitz M, Koreth J, Landau H, Brunstein C, McCarthy P, Qazilbash M, Giralt S, Krishnan A, Flynn K. Trajectories of symptom and quality-of-life (QOL) recovery after autologous stem cell transplantation (ASCT) in multiple myeloma (MM): secondary analysis of BMT CTN 0702 trial. QUALITY OF LIFE RESEARCH. 2021. p. S32–S33.